# BEAM THERAPEUTICS INC (BEAM)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/BEAM/

- Reporting holders: 4
- Reported value: $151.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $88.2K | 3,608 | 0.0% | 13 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $32.8K | 1,342 | 0.0% | 12 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $30.3K | 1,239 | 0.0% | 10 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $122 | 5 | 0.0% | 3 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $151.4K |
| Q2 2026 | 279 | $4.0B |
| Q1 2026 | 254 | $2.6B |
| Q4 2025 | 248 | $3.0B |
| Q3 2025 | 226 | $2.6B |
| Q2 2025 | 218 | $1.9B |
| Q1 2025 | 236 | $2.0B |
| Q4 2024 | 233 | $2.0B |
| Q3 2024 | 223 | $2.0B |
| Q2 2024 | 217 | $1.9B |
| Q1 2024 | 226 | $2.7B |
| Q4 2023 | 191 | $2.0B |